PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, F-35000, Rennes, France.\', \'INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, F-35000, Rennes, France; CHU Rennes, Laboratoire de toxicologie médico-légale, F-35000, Rennes, France.\', \'Department of Medical and Toxicological Critical Care, Lariboisière Hospital, University of Paris, INSERM, UMRS, 1144, Paris, France.\', \'INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, F-35000, Rennes, France. Electronic address: bernard.fromenty@inserm.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0300-9084(20)30203-010.1016/j.biochi.2020.08.018
?:doi
?:hasPublicationType
?:journal
  • Biochimie
is ?:pmid of
?:pmid
?:pmid
  • 32891697
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.554
?:rankingScore_hIndex
  • 116
is ?:relation_isRelatedTo_publication of
?:title
  • Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32891697>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32891697>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all